Related Experiment Video
Updated: Apr 4, 2026

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
Published on: June 29, 2019
[A clinical study of functional dyspepsia and mental disorder co-morbidity]
Liming Zhu, Xia Hong, Xiucai Fang
1Department of Psychological Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China;
Objective:
To investigate the co-morbid state of mental disorder in patients with functional dyspepsia (FD) in a tertiary general hospital in China and explore the risk factors of the co-morbidity of FD and major depressive disorder (MDD).
Methods:
This study was designed as a bilateral evaluation and structural psychiatric interview. Patients with FD and newly diagnosed outpatients with MDD in gastrointestinal and psychological departments were enrolled. FD was defined by Rome III criteria. The questionnaires including symptoms of FGIDs Roma III, the composite international diagnostic interview (CIDI 3.0) Chinese version, the Hamilton depression/anxiety rating scale (HAMD/HAMA), Montgomery-Asberg depression scale (MADRS) were involved in this study. All patients were administered by well trained physicians and investigators in face to face interview.
Results:
A total of 69 patients have completed the valid questionnaires and interview, among whom 42 met FD criteria (FD group) and 27 with FD co-morbid MDD (co-morbid group). Male to female ratios were 17:25 and 10:17, the mean age (42.1 ± 13.3) and (43.1 ± 15.3) years respectively. The life-long co-morbidity of FD and MDD was 39.1% (27/69), while 31.9% (22/69) patients with FD were accompanied with other mental disorders rather than MDD. Patients in FD co-morbid MDD group had significantly more severe depression than those in FD group with HAMD-17 score 21.6±8.0 and 14.5 ± 7.6, HAMA score 21.2 ± 9.0 and 14.9 ± 7.5 respectively (all P<0.01). Logistic regression analysis showed that high score of MADRS and complication with functional anorectal disorder may be the risk factors of FD co-morbid MDD [OR(95% CI) 1.12(1.06-1.19) and 7.07(1.12-44.53)].
Conclusions:
The co-morbidity rate of FD with MDD in our hospital is high. In addition to MDD, other mental disorders also need to be paid attention in FD patients. FD co-morbid MDD patients suffered more severe depression and anxiety. The high score of MADRS and complication with functional anorectal disorder seem to be the risk factors of co-morbidity of FD and MDD.
More Related Videos
03:05Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study
Published on: November 21, 2025
09:14Exploring the Neural Correlates of Cognitive Reappraisal in Obsessive-Compulsive Disorder Using Task-based Functional Magnetic Resonance Imaging
Published on: March 14, 2025
Related Concept Videos
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Assessment of the Gastrointestinal System I: Subjective Data
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
Assessment of the Gastrointestinal System II: Health Perception Pattern
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include:
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...